Supply Chain

While Deerfield, Ill.-based Walgreens Boots Alliance is reportedly in discussions to acquire AmerisourceBergen, analysts speculate the move may fail to keep Walgreens competitive in an ever-changing healthcare market, Reuters reports.

The FDA cleared Viz.AI, a San Francisco-based health IT company, to market its clinical decision support software for stroke care Feb. 13.

Bristol-Myers Squibb will pay Nektar Therapeutics $1 billion to develop a cancer immunotherapy treatment — one of the largest deals ever inked for a single drug's development, reports Reuters.

The FDA approved Teligent's betamethasone dipropionate lotion Wednesday.

The FDA approved Vertex Pharmaceutical's third treatment for cystic fibrosis Monday, according to Reuters.

FDA Commissioner Scott Gottlieb, MD, on Tuesday outlined several initiatives the agency would take to improve patient treatments and lower healthcare costs, using resources proposed in its recent budget request.

After just 10 months at the helm, Axovant's CEO David Hung, MD, resigned Monday to "pursue other opportunities." In addition, Axovant's president and COO Marion McCourt and three board members also stepped down.

Studies backed by the National Institutes of Health contributed to the science that underlies every one of the 210 new drugs approved between 2010 and 2016, according to a new study published in the Proceedings of the National Academy of…

To protect their bottom line amid ever-increasing drug prices, most hospitals agree they must implement cost containment strategies for medication spend.  However, realizing and sustaining cost savings over time is an achievement few obtain.

Scott Gottlieb, MD, stepped into his role as FDA commissioner amid much scrutiny over his deep ties to the drug and device industry. More than nine months into his leadership position, Dr. Gottlieb has managed an impressive feat for an…